TNAP and P2X7R: New plasma biomarkers for Alzheimer's disease
Paloma Aivar, Carolina Bianchi, Caterina Di Lauro, Lucía Soria-Tobar, Beatriz Alvarez-Castelao, Miguel Calero, Miguel Medina, Miguel Diaz-Hernández · FENS Forum 2024
Over the last few years, intense research efforts have been made to anticipate or improve the diagnosis of Alzheimer's disease by detecting blood biomarkers. However, the most promising blood biomarkers identified to date have some limitations, most of them related to the techniques required for their detection. Hence, new blood biomarkers should be identified to improve the diagnosis of AD, better discriminate between AD and mild cognitive impairment (MCI) and identify cognitively unimpaired (CU) older individuals at risk for progression to AD. Our previous studies demonstrated that both the
ePoster · Neuroscience